QualityStocksNewsBreaks Archives

WednesdaySep 30, 2026 3:50 pm

QualityStocksNewsBreaks – Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) (FSE: W1H) Preps ONC010 for Clinical Translation

Disseminated on behalf of Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) (FSE: W1H) and may include paid advertising. Onco-Innovations (CBOE CA: ONCO)(OTCQB: ONNVF)(FSE: W1H) is advancing its preclinical oncology candidate ONC010, a nanoparticle-encapsulated PNKP inhibitor designed to disrupt DNA-repair mechanisms involved in cancer survival and treatment resistance, while building the manufacturing, regulatory and financial infrastructure needed for clinical development. The company reports completing a 300-gram API scale-up with approximately 99.3% purity, expanding manufacturing capabilities through a partnership with Nanosoft Polymers, and progressing metabolism, analytical, licensing and other IND-enabling activities. It has also arranged approximately CAD$5 million in institutional financing, to be released through 18 monthly tranches, to…

WednesdaySep 30, 2026 3:30 pm

QualityStocksNewsBreaks – Why SuperQ Quantum Computing Inc. (CSE: QBTQ) (OTCQB: QBTQF) (FSE: 25X) Is ‘One to Watch’

Disseminated on behalf of SuperQ Quantum Computing Inc. and may include paid advertisements. SuperQ Quantum (CSE: QBTQ) (OTCQB: QBTQF) (FSE: 25X) was featured in a recent article that discussed its focus on reducing the technical and financial barriers to commercial adoption of advanced computing. “The company combines quantum computing with classical high-performance computing to address complex optimization, cybersecurity and decision-making challenges for enterprises, governments and research institutions,” the publication reads. “SuperQ’s approach is centered on making advanced computational resources more accessible and commercially practical through an integrated ecosystem of software, hardware and AI-driven technologies. The company is developing solutions intended…

WednesdaySep 30, 2026 2:24 pm

QualityStocksNewsBreaks – TruGolf Holdings, Inc. (NASDAQ: TRUG) Announces First TruGolf Range Installation Featuring AI Coach

TruGolf (NASDAQ: TRUG) announced the first installation of its indoor range platform, TruGolf Range, featuring the company’s new TruGolf AI Coach experience at Lucid Golf in New Albany, Indiana. TruGolf Range allows up to five players to practice simultaneously on a single cinematic screen, with each hitting bay providing slow-motion replay of club and ball interaction, ball flight data and integrated AI analysis of swing tendencies. The Lucid Golf installation will include TruGolf AI Coach, which analyzes player shot data and tendencies to provide insights, instruction and drills. TruGolf Range also features structured training workflows, skills challenges and games and…

WednesdaySep 30, 2026 11:46 am

QualityStocksNewsBreaks – Alphabet Inc. (NASDAQ: GOOGL) (NASDAQ: GOOG) Shares Rise About 2% as Google Joins Voluntary AI Safety Accord

Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) shares rose about 2% to $344.03 Wednesday morning as investors weighed Google’s participation in a voluntary AI safety accord, according to a GuruFocus article by Khac Phu Nguyen. The accord calls for internal controls, independent audits and safeguards intended to prevent AI systems from accessing technical infrastructure in unintended ways, while board committees would oversee audit findings. The article noted that the commitments remain voluntary and could provide greater policy clarity while adding compliance costs. GuruFocus said credible safeguards could help Google attract cloud customers handling sensitive information, though testing and audit requirements could increase…

WednesdaySep 30, 2026 10:39 am

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Co-Founder Discusses Lucid-MS Phase 2 Program, unbuzzd(TM) in BioMedWire Podcast

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Co-Founder and Executive Co-Chair Anthony Durkacz returned to The BioMedWire Podcast to discuss the company’s Lucid-MS drug candidate, which is advancing to a Phase 2 trial in multiple sclerosis patients, as well as the development and commercial opportunity surrounding unbuzzd(TM). Durkacz said Lucid-MS targets myelin and that the upcoming trial will mark the first time the drug is tested in patients with multiple sclerosis. He also highlighted clinical results for unbuzzd(TM), which is designed to accelerate alcohol metabolism,…

WednesdaySep 30, 2026 10:20 am

QualityStocksNewsBreaks – Quarterhill Inc. (TSX: QTRH) (OTCQX: QTRHF) Secures $60 Million Credit Facility With $100 Million Accordion

This article has been disseminated on behalf of Quarterhill Inc. and may include paid advertising. Quarterhill (TSX: QTRH) (OTCQX: QTRHF) secured a $60 million senior secured credit facility with U.S. Private Credit Investments (“PCI”), a division of BTG Pactual Global Alternatives, with Roth Canada serving as co-lead debt advisor. The financing consists of a $30 million initial term loan facility, a $25 million delayed draw term loan facility and a $5 million revolving credit facility. Proceeds will be used to repay obligations under Quarterhill’s existing credit agreement, redeem its convertible debentures, pay transaction fees and expenses and provide working capital.…

TuesdaySep 29, 2026 3:46 pm

QualityStocksNewsBreaks – Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Builds Momentum at Santa Fe

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising. Gold’s resilience in 2026, supported by central-bank purchases, geopolitical uncertainty and investor demand for hard assets, is creating a potentially favorable backdrop for gold developers such as Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF). The company is advancing its flagship Santa Fe Mine in Nevada toward a potential 2027 restart, building on existing mining and processing infrastructure and a recently expanded mineral resource. Lahontan reported a 22% increase in Santa Fe’s Mineral Resource Estimate to approximately 1.195 million ounces of gold equivalent in the Indicated…

TuesdaySep 29, 2026 3:25 pm

QualityStocksNewsBreaks – BOXABL Inc. (NASDAQ: BXBL) Brings Tech-Driven Housing Strategy to Public Markets

BOXABL (NASDAQ: BXBL) recently commenced trading on the Nasdaq following approval of its SPAC merger, marking its transition to the public markets at an implied valuation of approximately $3.5 billion. The company has raised more than $230 million from over 50,000 investors and has produced more than 800 modular homes as it develops a technology-driven, factory-based approach to residential construction. BOXABL manufactures standardized housing units at its Las Vegas facility, emphasizing automation, standardized production and AI-enabled manufacturing to improve efficiency and reduce costs. Its flagship 361-square-foot Casita is complemented by the smaller Baby Box, while larger modular formats are being…

TuesdaySep 29, 2026 2:49 pm

QualityStocksNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Moves VXA-222 Bispecific ADC to Next Development Stage

VERAXA Biotech (NASDAQ: VRXA) has advanced its VXA-222 bispecific antibody-drug conjugate (“ADC”) program beyond the initial discovery phase following the completion of its collaboration with OmniAb, with the company now planning to engineer the final candidate using its antibody-engineering, linker and conjugation technologies and conduct in vitro and in vivo preclinical studies. VXA-222 employs an “AND-gate” design intended to recognize two tumor-associated antigens simultaneously, potentially increasing selectivity for cancer cells, while VERAXA continues developing a broader oncology pipeline spanning ADCs, T-cell engagers and other engineered antibody formats. The company has also filed its first patents covering its BiTAC-TCE and BiTAC-ADC…

TuesdaySep 29, 2026 2:05 pm

QualityStocksNewsBreaks – Earth Science Tech Inc. (ETST) Adds California Hub to Growing Pharmacy Network

Earth Science Tech (OTC: ETST) recently continued its expansion in the healthcare, pharmacy and telemedicine sectors with the acquisition of Meduvo LLC, a California-based compounding pharmacy operating from a 2,000-square-foot facility in La Verne. The acquisition expands ETST’s pharmacy network to 34 U.S. jurisdictions and gives the company a West Coast operational hub, complementing its existing compounding pharmacy subsidiaries, RxCompoundStore.com and Mister Meds. The company plans to upgrade Meduvo’s facility to meet sterile-compounding requirements, with management targeting regulatory certification by the end of 2028. The acquisition fits ETST’s broader strategy of expanding its geographic reach, integrating telemedicine with pharmacy fulfillment…

Site Search

Company Search

Category: QualityStocksNewsBreaks